Clinical Complications and Their Management

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a cascade of events responsible for several clinical complications. This pathophysiologic mechanism can be partially controlled by blood transfusions or by correction of the severity of ineffective erythropoiesis. Thalassemias include a spectrum of phenotypes. Two main groups can be clinically distinguished: transfusion-dependent (TDT) and non–transfusion-dependent (NTDT) thalassemia. Both conditions are characterized by several clinical complications along life; some are shared, whereas some have higher prevalence in one group over the other. The authors present the most common clinical complications in TDT and NTDT and their management.

Original languageEnglish
Pages (from-to)223-236
Number of pages14
JournalHematology/Oncology Clinics of North America
Volume32
Issue number2
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Thalassemia
Erythropoiesis
Hemolysis
Blood Transfusion
Phenotype

Keywords

  • Endocrinopathies
  • Heart failure
  • Ineffective erythropoiesis
  • Iron overload
  • Liver disease
  • Thalassemia

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Clinical Complications and Their Management. / Marcon, Alessia; Motta, Irene; Taher, Ali T.; Cappellini, Maria Domenica.

In: Hematology/Oncology Clinics of North America, Vol. 32, No. 2, 01.04.2018, p. 223-236.

Research output: Contribution to journalReview article

@article{73947f201b874956b515cdaccef5b3e7,
title = "Clinical Complications and Their Management",
abstract = "The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a cascade of events responsible for several clinical complications. This pathophysiologic mechanism can be partially controlled by blood transfusions or by correction of the severity of ineffective erythropoiesis. Thalassemias include a spectrum of phenotypes. Two main groups can be clinically distinguished: transfusion-dependent (TDT) and non–transfusion-dependent (NTDT) thalassemia. Both conditions are characterized by several clinical complications along life; some are shared, whereas some have higher prevalence in one group over the other. The authors present the most common clinical complications in TDT and NTDT and their management.",
keywords = "Endocrinopathies, Heart failure, Ineffective erythropoiesis, Iron overload, Liver disease, Thalassemia",
author = "Alessia Marcon and Irene Motta and Taher, {Ali T.} and Cappellini, {Maria Domenica}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.hoc.2017.11.005",
language = "English",
volume = "32",
pages = "223--236",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Clinical Complications and Their Management

AU - Marcon, Alessia

AU - Motta, Irene

AU - Taher, Ali T.

AU - Cappellini, Maria Domenica

PY - 2018/4/1

Y1 - 2018/4/1

N2 - The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a cascade of events responsible for several clinical complications. This pathophysiologic mechanism can be partially controlled by blood transfusions or by correction of the severity of ineffective erythropoiesis. Thalassemias include a spectrum of phenotypes. Two main groups can be clinically distinguished: transfusion-dependent (TDT) and non–transfusion-dependent (NTDT) thalassemia. Both conditions are characterized by several clinical complications along life; some are shared, whereas some have higher prevalence in one group over the other. The authors present the most common clinical complications in TDT and NTDT and their management.

AB - The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a cascade of events responsible for several clinical complications. This pathophysiologic mechanism can be partially controlled by blood transfusions or by correction of the severity of ineffective erythropoiesis. Thalassemias include a spectrum of phenotypes. Two main groups can be clinically distinguished: transfusion-dependent (TDT) and non–transfusion-dependent (NTDT) thalassemia. Both conditions are characterized by several clinical complications along life; some are shared, whereas some have higher prevalence in one group over the other. The authors present the most common clinical complications in TDT and NTDT and their management.

KW - Endocrinopathies

KW - Heart failure

KW - Ineffective erythropoiesis

KW - Iron overload

KW - Liver disease

KW - Thalassemia

UR - http://www.scopus.com/inward/record.url?scp=85039718077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039718077&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2017.11.005

DO - 10.1016/j.hoc.2017.11.005

M3 - Review article

AN - SCOPUS:85039718077

VL - 32

SP - 223

EP - 236

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 2

ER -